WMT

125.11

-0.71%↓

COST

996.16

-0.57%↓

PG

151.49

-0.36%↓

KO

77.6

-0.26%↓

PM

172.78

-1.1%↓

WMT

125.11

-0.71%↓

COST

996.16

-0.57%↓

PG

151.49

-0.36%↓

KO

77.6

-0.26%↓

PM

172.78

-1.1%↓

WMT

125.11

-0.71%↓

COST

996.16

-0.57%↓

PG

151.49

-0.36%↓

KO

77.6

-0.26%↓

PM

172.78

-1.1%↓

WMT

125.11

-0.71%↓

COST

996.16

-0.57%↓

PG

151.49

-0.36%↓

KO

77.6

-0.26%↓

PM

172.78

-1.1%↓

WMT

125.11

-0.71%↓

COST

996.16

-0.57%↓

PG

151.49

-0.36%↓

KO

77.6

-0.26%↓

PM

172.78

-1.1%↓

Search

USANA Health Sciences Inc

Slēgts

17.63 0.46

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

17.4

Max

17.92

Galvenie mērījumi

By Trading Economics

Ienākumi

5.1M

-1.6M

Pārdošana

13M

226M

P/E

Sektora vidējais

30.241

28.214

EPS

-0.15

Peļņas marža

-0.705

Darbinieki

1,700

EBITDA

16M

28M

Dividendes

By Dow Jones

Nākamie ieņēmumi

2026. g. 21. apr.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-61M

321M

Iepriekšējā atvēršanas cena

17.17

Iepriekšējā slēgšanas cena

17.63

Tehniskais rādītājs

By Trading Central

Pārliecība

Weak Bullish Evidence

USANA Health Sciences Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 17. marts 22:42 UTC

Peļņas

Prudential PLC 2025 Adjusted Operating Profit Rises

2026. g. 17. marts 21:40 UTC

Peļņas

Alimentation Couche-Tard Records Higher Profit, Revenue in 3Q

2026. g. 17. marts 23:56 UTC

Tirgus saruna

BHP's Next CEO Likely to Build On Existing Strategic Direction -- Market Talk

2026. g. 17. marts 23:46 UTC

Tirgus saruna

Nikkei May Rise After Recent Selloffs -- Market Talk

2026. g. 17. marts 23:42 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 17. marts 23:42 UTC

Tirgus saruna

RBA's Return to Policy Tightening Will Work -- Market Talk

2026. g. 17. marts 23:38 UTC

Tirgus saruna

Gold Edges Lower on Possible Position Adjustments Before FOMC Decision -- Market Talk

2026. g. 17. marts 23:24 UTC

Tirgus saruna

Global Energy Roundup: Market Talk

2026. g. 17. marts 23:24 UTC

Tirgus saruna

New Woodside CEO Seen as Low-Risk Appointment -- Market Talk

2026. g. 17. marts 22:22 UTC

Tirgus saruna

BHP Hands Reins to Growth-Focused Executive -- Market Talk

2026. g. 17. marts 22:20 UTC

Peļņas

Prudential PLC 2025 New Business Profit $2.78B Vs. $2.46B >2378.HK

2026. g. 17. marts 22:20 UTC

Peļņas

Prudential PLC 2025 Adj Operating Profit $3.31B Vs. $3.13B >2378.HK

2026. g. 17. marts 22:07 UTC

Peļņas

Nvidia Says It Is Restarting Production of AI Chips for Sale in China -- WSJ

2026. g. 17. marts 22:05 UTC

Peļņas

ZTO Express (Cayman): Frank Zhen Wei to Resign From Board

2026. g. 17. marts 22:04 UTC

Peļņas

ZTO Express (Cayman): Board Approves Repurchase of Up to $1.5B of Shares Over Next 24 Months >ZTO

2026. g. 17. marts 22:03 UTC

Peļņas

ZTO Express (Cayman) Raises Semiannual Dividend to 39c Vs. 30c >ZTO

2026. g. 17. marts 22:01 UTC

Peļņas

ZTO Express (Cayman) 4Q Adj EPS 47c >ZTO

2026. g. 17. marts 22:01 UTC

Peļņas

ZTO Express (Cayman) 4Q Rev $2.08B >ZTO

2026. g. 17. marts 22:01 UTC

Peļņas

ZTO Express (Cayman) 4Q EPS 47c >ZTO

2026. g. 17. marts 21:26 UTC

Peļņas

Oklo Stock Wavers After Earnings, but the Nuclear Start-Up Has Good News -- Barrons.com

2026. g. 17. marts 21:09 UTC

Peļņas

Couche-Tard: 12 Company-Operated Stores Acquired During 3Q

2026. g. 17. marts 21:08 UTC

Peļņas

Couche-Tard 3Q Consolidated Same-Store Merchandise Revenue Up 2% >ATD.T

2026. g. 17. marts 21:08 UTC

Peļņas

Couche-Tard 3Q Adj EPS 81c >ATD.T

2026. g. 17. marts 21:07 UTC

Peļņas

Couche-Tard 3Q EPS 82c >ATD.T

2026. g. 17. marts 21:06 UTC

Peļņas

Couche-Tard 3Q Rev $21.8B >ATD.T

2026. g. 17. marts 21:05 UTC

Peļņas

Couche-Tard 3Q Adj EPS 81c >ATD.T

2026. g. 17. marts 21:05 UTC

Peļņas

Couche-Tard 3Q Rev $21.8B >ATD.T

2026. g. 17. marts 21:05 UTC

Peļņas

Couche-Tard 3Q EPS 82c >ATD.T

2026. g. 17. marts 21:05 UTC

Peļņas

Couche-Tard 3Q Net $757.2M >ATD.T

2026. g. 17. marts 20:50 UTC

Tirgus saruna
Galvenie ziņu notikumi

Energy & Utilities Roundup: Market Talk

Salīdzinājums

Cenas izmaiņa

USANA Health Sciences Inc Prognoze

Vērtējuma vienprātība

By TipRanks

0 ratings

0

Pirkt

0

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

28.405 / 29.84Atbalsts un pretestība

Īstermiņā

Weak Bullish Evidence

Vidējā termiņā

Bullish Evidence

Ilgtermiņā

No Evidence

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
help-icon Live chat